Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jack Nielsen currently holds 6,336 shares of Aligos Therapeutics, Inc. (ALGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack Nielsen has been a net seller of ALGS stock. They have purchased $16.3M and sold $96.5M worth of shares.
Jack Nielsen's most recent insider trade was on May 29, 2024, when they sold 6,336 shares at $0.00 per share.
Jack Nielsen serves as Executive at Aligos Therapeutics, Inc. (ALGS). They have executed 84 insider transactions totaling $112.9M over their tenure at the company.
Jack Nielsen holds the position of Executive at Aligos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Jack Nielsen has shown a selling trading pattern, with $16.3M in total purchases and $96.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jack Nielsen was on Jul 7, 2022, when they sold $10.1M worth of HRMY shares. This transaction involved 180,838 shares at $56.01 per share.
Jack Nielsen currently owns 6,336 shares of Aligos Therapeutics, Inc. (ALGS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jack Nielsen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jack Nielsen has 84 Form 4 filings on record as an insider at Aligos Therapeutics, Inc..
Set alerts for Jack Nielsen and 40,000+ other insiders.